Skip to main content

Table 4 Characteristics of the studied sample according to staging

From: Impact of the SARS-CoV-2 on the journey of high-risk colon cancer patients within the scope of the Unified Health System in Brazil

Variables

Stage

P value

II

III

IV

Sex

    

Female

21 (58.33%)

59 (64.17%)

57 (58.76%)

0.709q

Male

15 (41.67%)

33 (35.87%)

40 (41.24%)

Marital status

    

Single

14 (42.42%)

27 (31.40%)

31 (36.05%)

0.352 mc

Married

17 (51.52%)

39 (45.35%)

38 (44.19%)

Widow

1 (3.03%)

10 (11.63%)

12 (13.95%)

Divorced

1 (3.03%)

10 (11.63%)

5 (5.81%)

Skin color

    

White

7 (20.00%)

21 (23.33%)

22 (23.66%)

0.956 mc

Black

3 (8.57%)

5 (5.56%)

7 (7.53%)

Brown

25 (71.43%)

64 (71.11%)

64 (68.82%)

Education

    

Illiterate

1 (3.57%)

1 (1.47%)

3 (4.41%)

0.269mc

Unfinished elementary education

4 (14.29%)

23 (33.82%)

23 (33.82%)

Finished elementary education

12 (42.86%)

21 (30.88%)

18 (26.47%)

Finished secondary education

6 (21.43%)

14 (20.59%)

20 (29.41%)

Finished higher education

5 (17.86%)

9 (13.24%)

4 (5.88%)

Place of residence

    

Belo Horizonte

22 (61.11%)

50 (54.35%)

53 (54.64%)

0.764q

Others

14 (38.89%)

42 (45.65%)

44 (45.36%)

Comorbidities

    

Yes

24 (66.67%)

67 (72.83%)

59 (60.82%)

0.217q

No

12 (33.33%)

25 (27.17%)

38 (39.18%)

Period

    

Pre-COVID-19

20 (55.56%)

35 (38.04%)

52 (53.61%)

0.058q

COVID-19

16 (44.44%)

57 (61.96%)

45 (46.39%)

Time between diagnostic colonoscopy and beginning of systemic treatment

    

Median (SD)

94 (31)

84 (33)

92 (42)

0.392kw

Time between diagnostic surgery and beginning of systemic treatment

    

Median (SD)

84.42 (24.73)

78.38 (24.20)

83.11 (42.52)

0.256kw

  1. mc: Chi-squared with Monte Carlo simulation; q: Chi-square test; kw: Kruskal-Wallis test; SD: Standard deviation